.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Chubb
McKesson
US Department of Justice
Argus Health
Queensland Health
Cantor Fitzgerald
McKinsey
Novartis
AstraZeneca

Generated: December 15, 2017

DrugPatentWatch Database Preview

OLANZAPINE AND FLUOXETINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Olanzapine And Fluoxetine Hydrochloride, and what generic alternatives are available?

Olanzapine And Fluoxetine Hydrochloride is a drug marketed by Par Pharm, Sandoz, and Teva Pharms. and is included in four NDAs.

The generic ingredient in OLANZAPINE AND FLUOXETINE HYDROCHLORIDE is fluoxetine hydrochloride; olanzapine. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride; olanzapine profile page.

Summary for OLANZAPINE AND FLUOXETINE HYDROCHLORIDE

Drug patent expirations by year for OLANZAPINE AND FLUOXETINE HYDROCHLORIDE

Pharmacology for OLANZAPINE AND FLUOXETINE HYDROCHLORIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Par PharmOLANZAPINE AND FLUOXETINE HYDROCHLORIDEfluoxetine hydrochloride; olanzapineCAPSULE;ORAL077742-001Nov 2, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozOLANZAPINE AND FLUOXETINE HYDROCHLORIDEfluoxetine hydrochloride; olanzapineCAPSULE;ORAL078901-001Nov 16, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmOLANZAPINE AND FLUOXETINE HYDROCHLORIDEfluoxetine hydrochloride; olanzapineCAPSULE;ORAL077742-004Nov 2, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva PharmsOLANZAPINE AND FLUOXETINE HYDROCHLORIDEfluoxetine hydrochloride; olanzapineCAPSULE;ORAL077528-001Jun 19, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozOLANZAPINE AND FLUOXETINE HYDROCHLORIDEfluoxetine hydrochloride; olanzapineCAPSULE;ORAL078901-003Nov 16, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva PharmsOLANZAPINE AND FLUOXETINE HYDROCHLORIDEfluoxetine hydrochloride; olanzapineCAPSULE;ORAL077528-003Jun 19, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmOLANZAPINE AND FLUOXETINE HYDROCHLORIDEfluoxetine hydrochloride; olanzapineCAPSULE;ORAL077742-002Nov 2, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmOLANZAPINE AND FLUOXETINE HYDROCHLORIDEfluoxetine hydrochloride; olanzapineCAPSULE;ORAL077742-003Nov 2, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozOLANZAPINE AND FLUOXETINE HYDROCHLORIDEfluoxetine hydrochloride; olanzapineCAPSULE;ORAL078901-005Nov 16, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmOLANZAPINE AND FLUOXETINE HYDROCHLORIDEfluoxetine hydrochloride; olanzapineCAPSULE;ORAL077742-005Nov 2, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Chubb
Cipla
Cerilliant
Novartis
Medtronic
Mallinckrodt
Teva
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot